Serigne Lo
University of Sydney(AU)The University of Sydney(AU)University of British Columbia(CA)Tuen Mun Hospital(CN)Liverpool Hospital(AU)Occupational Cancer Research Centre(CA)Migration Institute of Australia(AU)Melanoma Institute Australia(AU)National Taiwan Sport University(TW)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, CAR-T cell therapy research
Most-Cited Works
- → Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy(2019)1,005 cited
- → Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study(2018)982 cited
- → Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer(2022)910 cited
- → Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)(2021)418 cited
- → Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets(2019)326 cited
- → Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma(2017)322 cited